AI-generated content for informational purposes only. Not financial advice. Always do your own research.

About

MetLife, Inc. (NYSE: MET) is a global leader in insurance, annuities, and employee benefit programs, serving approximately 100 million customers across more than 40 countries. The company operates through segments including U.S., Asia, Latin America, and Europe, the Middle East and Africa, offering group and individual life insurance, dental, disability, and retirement and savings products. MetLife stands out as an insurance stock due to its international diversification and dominant position in the U.S. group benefits market.

Insurance Stocks

MetLife is a globally diversified insurance stock with leadership in both life insurance and employee benefits. Its extensive international presence and scale in group benefits differentiate it from domestic-focused insurers, offering investors broad exposure to global insurance demand.

Key Financials MET

Price $77.31
Change (1D) -0.06%
Change (30D) -2.06%
Change (60D) +2.36%
Change (90D) -6.12%
Change (180D) -0.87%
Change (1Y) -6.55%
Change (5Y) +42.06%
P/E Ratio 8.75
EPS (TTM) $8.84
52-Week Range $65.21 โ€” $87.39
50-Day MA $78.86
Volume 3.11M

Data updated Feb 15 ยท Source: Twelve Data

4.2 2 reviews

AI Reviews

๐Ÿค–
4.1 /5

MetLife is one of the world's largest insurance and employee benefits providers, with a diversified global footprint spanning the U.S., Asia, Latin America, and EMEA. The stock trades at a compelling P/E of 8.75 with strong EPS of $8.84, reflecting the value-oriented nature typical of large-cap insurers. The 42% five-year return demonstrates solid long-term wealth creation, though the stock has pulled back roughly 6.5% over the past year and sits below its 50-day moving average, suggesting near-term momentum headwinds.

Bull case: MetLife's diversified revenue streams, disciplined capital return program (consistent buybacks and dividends), and exposure to higher interest rates supporting investment income make it attractive at current valuations. The Group Benefits segment provides stable, recurring revenue.

Bear case: Sensitivity to equity market volatility through variable annuity guarantees, macroeconomic uncertainty impacting international operations, and potential for elevated catastrophe losses pose risks. Competition from insurtechs and evolving regulatory landscapes add pressure.

Overall, MetLife offers a solid value proposition for income-oriented investors seeking insurance sector exposure at a reasonable price.

Category Ratings

Insurance Stocks
4.1
Feb 15, 2026
AI-Generated Review Generated via Anthropic API. This is an automated evaluation, not a consumer review. Learn more
๐Ÿค–
4.2 /5

MetLife stands as a dominant force in the global life insurance and employee benefits sector, offering a compelling value proposition with a P/E ratio of approximately 10.9x. The company benefits significantly from its diversified geographic footprint across the U.S., Asia, and Latin America, which helps mitigate regional risks. Financially, MetLife is well-positioned to capitalize on the current interest rate environment, which generally boosts net investment income for insurers. With a robust EPS of $7.17, the company demonstrates strong earnings power and capital generation capabilities.

However, risks remain. Investors should closely monitor the company's investment portfolio exposure to commercial real estate, a sector facing ongoing volatility. Additionally, with the stock trading slightly below its 50-day moving average and off its 52-week high, there is some short-term technical consolidation. Overall, MET represents a solid, defensive choice for value-oriented investors seeking stability and exposure to the financial sector.

Category Ratings

Insurance Stocks
4.2
Feb 11, 2026
AI-Generated Review Generated via Google API. This is an automated evaluation, not a consumer review. Learn more
MetLife Screenshot

Added: Feb 10, 2026

metlife.com